Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS)
Open Access
- 1 November 2011
- journal article
- Published by Springer Science and Business Media LLC in BMC Endocrine Disorders
- Vol. 11 (1), 18
- https://doi.org/10.1186/1472-6823-11-18
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)Diabetes Care, 2011
- The Role of Testosterone in the Etiology and Treatment of Obesity, the Metabolic Syndrome, and Diabetes Mellitus Type 2Journal of Obesity, 2010
- Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice GuidelineJournal of Clinical Endocrinology & Metabolism, 2010
- Impact of Acute Biochemical Castration on Insulin Sensitivity in Healthy Adult MenEndocrine Research, 2010
- Fifty‐ two—Week Treatment With Diet and Exercise Plus Transdermal Testosterone Reverses the Metabolic Syndrome and Improves Glycemic Control in Men With Newly Diagnosed Type 2 Diabetes and Subnormal Plasma TestosteroneJournal of Andrology, 2009
- Harmonizing the Metabolic SyndromeCirculation, 2009
- The Dark Side of Testosterone Deficiency: I. Metabolic Syndrome and Erectile DysfunctionJournal of Andrology, 2009
- Prevalence of hypogonadism in males aged at least 45 years: the HIM studyInternational Journal of Clinical Practice, 2008
- Androgen Deprivation Therapy, Insulin Resistance, and Cardiovascular Mortality: An Inconvenient TruthJournal of Andrology, 2008
- Sex Differences of Endogenous Sex Hormones and Risk of Type 2 DiabetesJAMA, 2006